Metformin: Is it Still the First Line in Type 2 Diabetes Management Algorithm?

Volume: 27, Issue: 8, Pages: 1061 - 1067
Published: Apr 8, 2021
Abstract
Type 2 diabetes mellitus (T2DM) has an ever-growing prevalence worldwide, affecting 1 in 11 adults. It continues to significantly impact patients in terms of morbidity and mortality, in addition to impairing quality of life while adding to the spiralling healthcare costs. Metformin was first used over half a century ago, and for the past two decades, it has been considered first-line oral therapy to treat patients with T2DM, in whom lifestyle...
Paper Details
Title
Metformin: Is it Still the First Line in Type 2 Diabetes Management Algorithm?
Published Date
Apr 8, 2021
Volume
27
Issue
8
Pages
1061 - 1067
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.